The benefit of the doubt: PD-L1 status in unresectable stage III NSCLC management
@article{TCR72633, author = {Marie-Helene Denault and Cheryl Ho}, title = {The benefit of the doubt: PD-L1 status in unresectable stage III NSCLC management}, journal = {Translational Cancer Research}, volume = {12}, number = {3}, year = {2023}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/72633} }